4723-27-14 Pilot program data reporting and evaluation.

(A) The board shall evaluate data received from nursing homes and residential care facilities participating in the pilot program to assess whether or not certified medication aides are able to administer prescription medications safely to nursing home and residential care facility residents.

(B) Nursing homes and residential care facilities participating in the pilot program shall report on the form specified by the board the following data regarding a medication error involving a certified medication aide within five business days of the date on which the medication error occurred:

(1) The proprietary and generic name of the medication prescribed, and the name of the medication that was administered;

(2) The dosage of the medication prescribed, and the dosage of the medication that was administered;

(3) The time the medication was prescribed to be administered, and the time it was administered;

(4) The route the medication was prescribed to be administered, and the route it was administered;

(5) Whether the medication administered was outdated or expired according to the manufacturer label;

(6) Whether the medication was improperly prepared or stored;

(7) An identified individual or individuals who made the error, perpetuated the error and detected the error;

(8) The technique appropriate for the medication administration if the proper technique was not used;

(9) Whether the medication was administered to the wrong patient;

(10) Whether the task of administering the medication was not delegated or was improperly delegated to the certified medication aide;

(11) Whether the certified medication aide involved in the medication error performed other tasks or activities not directly related to the administration of medication during the shift in which the error occurred;

(12) The number of residents to whom the certified medication aide was delegated the task of medication administration at the time the medication error occurred;

(13) The number of certified medication aides the delegating nurse involved in the medication error was supervising at the time the medication error occurred;

(14) The number of certified medication aides administering medications at the nursing home or residential care facility at the time the medication error occurred;

(15) The date and time the medication error occurred;

(16) The number of hours that the certified medication aide involved in the medication error worked during the twenty-four hour time period immediately prior to the time the error occurred;

(17) A description of the medication dispensing, storage and administration system utilized by the nursing home or residential care facility;

(18) The cause of the error as determined by the reporting nursing home or residential care facility which may include but not be limited to the following:

(a) Verbal miscommunication;

(b) Written miscommunication;

(d) Misinterpretation of delegation directions;

(e) Proprietary medication name confusion;

(f) Generic medication name confusion; and

(19) The outcome for the resident involved in the medication error, including whether:

(a) The resident required transfer to an acute care facility;

(b) The resident required additional monitoring, medication, intervention or treatment at the nursing home or residential care facility; or

(C) In addition to the data reported in accordance with paragraph (B) of this rule, the nursing home or residential care facility shall:

(1) Submit a personal written statement from the certified medication aide involved in the medication error;

(2) Submit a personal written statement from the delegating nurse involved in the medication error;

(3) Provide an opportunity for a resident or other appropriate party to provide a personal statement relating to the medication error.

(D) Participating nursing homes and residential care facilities shall prepare and submit to the board not later than the thirty-first day after the board requests it under division (F)(1)(a) of section 4723.63 of the Revised Code, on a form specified by the board, all of the following:

(1) Data collected as of sixty days immediately prior to the date on which the report is to be submitted to the board in accordance with division (F)(1)(a) of section 4723.63 of the Revised Code, regarding costs and other financial matters pertaining to the use of certified medication aides at each nursing home or residential care facility participating in the pilot program;

(2) A summary prepared by a certified public accountant or the nursing home or residential care facility’s financial officer familiar with the facility’s accounting system that explains the financial implications of the reported costs and financial data as determined by the facility;

(3) A summary of the nursing home or residential care facility’s experience in utilizing certified medication aides, including but not limited to benefits, challenges and recommendations associated with the use of certified medication aides; and

(4) A statement by the nursing home or residential care facility regarding its perception of the quality and nature of the training received by the certified medication aides utilized in the facility.

(E) Not later than the one hundred eighty-first day after the day on which the board issues a medication aide certificate under section 4723.651 of the Revised Code to the seventy-fifth individual, the board, upon the advice of the medication aide advisory council, shall prepare and submit a report of its findings and recommendations derived from the evaluation of the reported data to the following entities:

(1) The governor;

(2) The president and minority leader of the senate;

(3) The speaker and minority leader of the house of representatives; and

(4) The director of health.

(F) The provisions of division (I) of section 4723.28 of the Revised Code apply to information received by the board in the course of evaluating and assessing the medication aide pilot program pursuant to section 4723.63 of the Revised Code. The board has all of the powers and duties conferred by sections 4723.28 and 4723.29 of the Revised Code with respect to the evaluation and assessment of the medication aide pilot program.

Effective: 02/01/2008

R.C. 119.032 review dates: 05/01/2011

Promulgated Under: 119.03

Statutory Authority: 4723.69

Rule Amplifies: 4723.61 to 4723.69

Prior Effective Dates: 2/1/06 (Emer.), 5/1/06